Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
BELBUCA53.2M33.39%
Xtampza Extended-release (ER)49.49M31.07%
Nucynta Immediate-release (IR)25.36M15.92%
Nucynta Extended-release (ER)19.77M12.41%
Jornay PM7.96M5.00%
Symproic3.52M2.21%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States566.77M100.00%
